A small study was published showing activity of imatinib in patients with KIT-mutant metastatic melanoma with an ORR of 29% and a median follow-up of 10.9 months (range, 3.6-27 months). 24 Similar ...

Genomic analyses. Next-generation sequencing was performed using the TruSight Tumor 15 kit from Illumina ®; this panel includes 15 genes commonly mutated in solid tumors.Among the mutated genes, two ...

This 4th approval of Qiagen’s therascreen KRAS RGQ PCR kit adds to the existing 3 therapies already indicated in the label for use in NSCLC and colorectal cancer (CRC). It builds on the company’s ...

Figure 1 Case 2, KRAS/BRAF genotyping: (A) qRT-PCR results using EasyPGX ® KRAS kit showing the KRAS G12V/D/A (c.35G>H) variant in tumor DNA. The assay detects but not distinguishes the c. 35G>T (G12V ...

KIT-mutant melanoma is not as common as BRAF-mutant melanoma, but in certain parts of the body like chronically sun-damaged skin or mucosal surfaces, when the melanoma rises from there, it's really ...

QIAGEN’s portfolio includes 10 FDA-approved PCR-based companion-diagnostics products, including therascreen EGFR, therascreen KRAS, therascreen FGFR, therascreen PIK3CA and the therascreen BRAF kit.

Biocept Inc (NASDAQ:BIOC) has released a new Target Selector molecular assay research-use-only (RUO) kit for clients to use in their own laboratories. The... This website uses cookies. We use cookies ...

The test is designed to detect BRAF mutations, among the most frequently evaluated biomarkers across many solid tumor cancers, including lung cancer and melanoma Target Selector kits are a ...